Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACHN

Achillion Pharmaceuticals (ACHN) Stock Price, News & Analysis

Achillion Pharmaceuticals logo

About Achillion Pharmaceuticals Stock (NASDAQ:ACHN)

Advanced Chart

Key Stats

Today's Range
$6.76
$6.76
50-Day Range
$6.76
$6.76
52-Week Range
$2.06
$7.01
Volume
N/A
Average Volume
8.44 million shs
Market Capitalization
$946.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACHN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achillion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACHN Stock News Headlines

Kim P. Kamdar's Net Worth
Lexicon Pharmaceuticals (NASDAQ: LXRX)
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
ACHN_old Historical Data
See More Headlines

ACHN Stock Analysis - Frequently Asked Questions

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) issued its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achillion Pharmaceuticals investors own include Chesapeake Energy (CHKAQ), Skyworks Solutions (SWKS), Madrigal Pharmaceuticals (MDGL), Noble (NEBLQ), Gilead Sciences (GILD), Eiger BioPharmaceuticals (EIGR) and Meta Platforms (META).

Company Calendar

Last Earnings
11/07/2019
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHN
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.27 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.92 per share
Price / Book
3.52

Miscellaneous

Free Float
N/A
Market Cap
$946.72 million
Optionable
Optionable
Beta
1.59
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ACHN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners